文献速递肝病消化道出血

TIPSS治疗异位静脉曲张出血的疗效差异:一项多中心回顾性研究

Variable efficacy of TIPSS in the management of ectopic variceal bleeding: a multicentre retrospective study.
PubMed 文献 · Aliment Pharmacol Ther · 2018-08-22

该多中心回顾性研究分析了1992至2016年间53例接受TIPSS的慢性肝病合并异位静脉曲张出血患者,中位随访14.0个月,再出血12例,1年累积再出血率23%,TIPSS对造口旁异位静脉曲张出血尤其有效,但对十二指肠异位静脉曲张出血可能效果不佳。

要点

  • TIPSS可为多数肝硬化异位静脉曲张出血患者提供长期出血控制。
  • 造口旁异位静脉曲张出血最常见,TIPSS对其尤其有效。
  • 十二指肠异位静脉曲张出血再出血比例较高,TIPSS可能效果不佳。

核心结论

  • TIPSS可为多数肝硬化异位静脉曲张出血患者提供长期出血控制。
  • TIPSS对造口旁异位静脉曲张出血尤其有效,但对十二指肠异位静脉曲张出血可能效果不佳。

研究设计与样本

  • 多中心回顾性分析,纳入1992至2016年三家三级中心连续收治的慢性肝病合并异位静脉曲张出血并接受TIPSS的患者53例。
  • 患者70%为男性,中位年龄61岁,中位MELD评分11。

主要发现

  • 异位静脉曲张位于造口旁40%、十二指肠23%、直肠17%及其他部位20%。
  • 四分之三的患者既往接受过内科、内镜或外科治疗但未成功。
  • 中位随访14.0个月,TIPSS后12例再出血:十二指肠静脉曲张6/12(50%)、直肠静脉曲张2/9(22%)、造口旁1/21、腹腔内1/3、肝管空肠吻合口1/2、升结肠1/2。
  • 再出血危险因素包括TIPSS置入时MELD评分(每分HR 1.081;95%CI 1.012-1.153;P=0.034)、静脉曲张位于非肠造口部位(HR 9.770;95%CI 1.241-76.917;P=0.030)及既往局部治疗(HR 5.710;95%CI 1.211-26.922;P=0.028)。
  • 估计累积再出血率1年23%、3年26%、5年32%;TIPSS后53例中16例(30%)出现肝性脑病新发或加重。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Evidence for the efficacy of TIPSS in ectopic variceal bleeding (EctVB) is largely based on relatively small series. AIM: To define the efficacy of TIPSS in EctVB. METHODS: Retrospective analysis of consecutive patients with chronic liver disease who presented with EctVB and received TIPSS in three tertiary centres in 1992-2016. RESULTS: The study included 53 patients (70% male, median age 61 years, median model for end-stage liver disease (MELD) score 11). The ectopic varices were located around the insertion of stomas (40%), duodenum (23%), rectum (17%) and at other sites (20%). Three-quarters of the patients had previously received unsuccessful medical, endoscopic or surgical therapy. The median follow-up was 14.0 months. Following TIPSS, bleeding recurred in 12 patients: 6 of 12 (50%) with duodenal varices, 2 of 9 (22%) with rectal varices and one each with stomal (1/21), intraperitoneal (1/3), hepaticojejunostomy (1/2) and ascending colon varices (1/2). The risk factors for re-bleeding were MELD score at TIPSS placement (HR: 1.081 per point; 95% confidence interval (CI): 1.012-1.153; P = 0.034), varices located at site other than an enterostomy (HR: 9.770; 95%CI: 1.241-76.917; P = 0.030) and previous local therapy (HR: 5.710; 95%CI: 1.211-26.922; P = 0.028). The estimated cumulative re-bleeding rate was 23% at 1 year, 26% at 3 years and 32% at 5 years. Post-TIPSS hepatic encephalopathy manifested or worsened in 16 of 53 patients (30%). CONCLUSION: TIPSS provides long-term control of bleeding in most cirrhotic patients with EctVB. TIPSS is particularly effective in stomal EctVB, the most frequent cause of EctVB, but might not be as effective in duodenal EctVB.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Oey RC, de Wit K, Moelker A, et al. Variable efficacy of TIPSS in the management of ectopic variceal bleeding: a multicentre retrospective study. Aliment Pharmacol Ther. 2018. PMID: 30136292. doi:10.1111/apt.14947

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。